PT81028B - Processo para a preparacao de composicoes farmaceuticas anti-histaminicas de fusao a quente em condicoes de proporcionarem uma libertacao prolongada do produto anti-histaminico, designadamente o alfa-(p-tert-butilfenil)-4-(alfa-hidroxi-alfa-fenilbenzil)-1-piperidinobutanol (terfenadina) - Google Patents
Processo para a preparacao de composicoes farmaceuticas anti-histaminicas de fusao a quente em condicoes de proporcionarem uma libertacao prolongada do produto anti-histaminico, designadamente o alfa-(p-tert-butilfenil)-4-(alfa-hidroxi-alfa-fenilbenzil)-1-piperidinobutanol (terfenadina) Download PDFInfo
- Publication number
- PT81028B PT81028B PT81028A PT8102885A PT81028B PT 81028 B PT81028 B PT 81028B PT 81028 A PT81028 A PT 81028A PT 8102885 A PT8102885 A PT 8102885A PT 81028 B PT81028 B PT 81028B
- Authority
- PT
- Portugal
- Prior art keywords
- terfenadine
- alpha
- weight
- capsule
- polyethylene glycol
- Prior art date
Links
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 229960000351 terfenadine Drugs 0.000 title claims description 37
- 239000000203 mixture Substances 0.000 claims abstract description 38
- 238000011049 filling Methods 0.000 claims abstract description 13
- 239000012943 hotmelt Substances 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims description 37
- 238000002360 preparation method Methods 0.000 claims description 23
- 229920001223 polyethylene glycol Polymers 0.000 claims description 16
- 239000012188 paraffin wax Substances 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 abstract description 14
- 230000001387 anti-histamine Effects 0.000 abstract description 4
- 239000000739 antihistaminic agent Substances 0.000 abstract description 4
- 238000013268 sustained release Methods 0.000 abstract description 4
- 239000012730 sustained-release form Substances 0.000 abstract description 4
- 239000007887 hard shell capsule Substances 0.000 abstract 1
- 239000007886 soft shell capsule Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 11
- 239000007903 gelatin capsule Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000945 filler Substances 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 230000009974 thixotropic effect Effects 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- -1 acetic Chemical class 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000005273 2-acetoxybenzoic acid group Chemical group 0.000 description 1
- 125000005274 4-hydroxybenzoic acid group Chemical group 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical class C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N hydroxymaleic acid group Chemical group O/C(/C(=O)O)=C/C(=O)O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229940050929 polyethylene glycol 3350 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64617984A | 1984-08-30 | 1984-08-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT81028A PT81028A (en) | 1985-09-01 |
| PT81028B true PT81028B (pt) | 1987-09-18 |
Family
ID=24592083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT81028A PT81028B (pt) | 1984-08-30 | 1985-08-26 | Processo para a preparacao de composicoes farmaceuticas anti-histaminicas de fusao a quente em condicoes de proporcionarem uma libertacao prolongada do produto anti-histaminico, designadamente o alfa-(p-tert-butilfenil)-4-(alfa-hidroxi-alfa-fenilbenzil)-1-piperidinobutanol (terfenadina) |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0173293B1 (en, 2012) |
| JP (1) | JPH0621068B2 (en, 2012) |
| KR (1) | KR920007832B1 (en, 2012) |
| AR (1) | AR242341A1 (en, 2012) |
| AT (1) | ATE68972T1 (en, 2012) |
| AU (1) | AU579177B2 (en, 2012) |
| CA (1) | CA1250526A (en, 2012) |
| DE (1) | DE3584557D1 (en, 2012) |
| DK (1) | DK164642C (en, 2012) |
| ES (1) | ES8608866A1 (en, 2012) |
| FI (1) | FI87992C (en, 2012) |
| GR (1) | GR852078B (en, 2012) |
| HU (1) | HU195421B (en, 2012) |
| IE (1) | IE58080B1 (en, 2012) |
| IL (1) | IL76237A (en, 2012) |
| NZ (1) | NZ213248A (en, 2012) |
| PH (1) | PH21083A (en, 2012) |
| PT (1) | PT81028B (en, 2012) |
| ZA (1) | ZA856482B (en, 2012) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8507779D0 (en) * | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
| AR240018A1 (es) * | 1987-10-07 | 1990-01-31 | Merrell Pharma Inc | Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol. |
| ZA90341B (en) * | 1989-01-23 | 1990-10-31 | Merrell Dow Pharma | Liquid pharmaceutical composition for piperidinoalkanol derivatives |
| EP0416585B1 (en) * | 1989-09-07 | 1996-06-05 | Fuji Photo Film Co., Ltd. | Method for processing a silver halide color photographic material |
| US5270064A (en) * | 1991-04-12 | 1993-12-14 | Avian Allure | Encapsulated food product with readily removable capsule |
| US5455045A (en) * | 1993-05-13 | 1995-10-03 | Syntex (U.S.A.) Inc. | High dose formulations |
| GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
| NZ302926A (en) * | 1995-02-28 | 1998-10-28 | Hoechst Marion Roussel Inc | Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients |
| US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| IL133420A (en) * | 1997-08-26 | 2004-07-25 | Aventis Pharma Inc | Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion |
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| FR2838349B1 (fr) * | 2002-04-15 | 2004-06-25 | Laurence Paris | Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication |
| EP1829541A1 (en) * | 2002-12-17 | 2007-09-05 | Abbott GmbH & Co. KG | Formulation comprising fenofibric acid or a physiologically acceptable salt thereof |
| JP2006511541A (ja) * | 2002-12-17 | 2006-04-06 | アボット ゲーエムベーハー ウント カンパニー カーゲー | フェノフィブル酸、その生理学的に許容し得る塩または誘導体を含有してなる製剤 |
| EP2042165A1 (de) * | 2007-09-28 | 2009-04-01 | Swiss Caps Rechte und Lizenzen AG | Hot-Melt-Befüllte Weichkapseln |
| FR2999937B1 (fr) * | 2012-12-21 | 2015-01-09 | Sanofi Sa | Unite solide a haute teneur en fexofenadine et son procede de preparation |
| US20170119680A1 (en) | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3139383A (en) * | 1961-06-26 | 1964-06-30 | Norton Co | Encapsulated time release pellets and method for encapsulating the same |
| US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
| GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
| DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
-
1985
- 1985-08-23 DK DK384985A patent/DK164642C/da not_active IP Right Cessation
- 1985-08-26 PT PT81028A patent/PT81028B/pt unknown
- 1985-08-26 ZA ZA856482A patent/ZA856482B/xx unknown
- 1985-08-26 CA CA000489380A patent/CA1250526A/en not_active Expired
- 1985-08-27 EP EP85110726A patent/EP0173293B1/en not_active Expired - Lifetime
- 1985-08-27 AT AT85110726T patent/ATE68972T1/de active
- 1985-08-27 DE DE8585110726T patent/DE3584557D1/de not_active Expired - Lifetime
- 1985-08-27 NZ NZ213248A patent/NZ213248A/xx unknown
- 1985-08-27 PH PH32706A patent/PH21083A/en unknown
- 1985-08-27 AU AU46692/85A patent/AU579177B2/en not_active Expired
- 1985-08-27 FI FI853275A patent/FI87992C/fi not_active IP Right Cessation
- 1985-08-28 IL IL76237A patent/IL76237A/xx not_active IP Right Cessation
- 1985-08-28 GR GR852078A patent/GR852078B/el unknown
- 1985-08-28 AR AR85301438A patent/AR242341A1/es active
- 1985-08-29 ES ES546545A patent/ES8608866A1/es not_active Expired
- 1985-08-29 JP JP60188736A patent/JPH0621068B2/ja not_active Expired - Lifetime
- 1985-08-29 HU HU853290A patent/HU195421B/hu unknown
- 1985-08-29 IE IE213485A patent/IE58080B1/en not_active IP Right Cessation
- 1985-08-30 KR KR1019850006317A patent/KR920007832B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT81028A (en) | 1985-09-01 |
| IL76237A (en) | 1989-01-31 |
| HUT38248A (en) | 1986-05-28 |
| JPH0621068B2 (ja) | 1994-03-23 |
| DE3584557D1 (de) | 1991-12-05 |
| EP0173293B1 (en) | 1991-10-30 |
| DK384985D0 (da) | 1985-08-23 |
| GR852078B (en, 2012) | 1985-12-30 |
| NZ213248A (en) | 1988-07-28 |
| FI853275L (fi) | 1986-03-01 |
| IE58080B1 (en) | 1993-06-30 |
| CA1250526A (en) | 1989-02-28 |
| IL76237A0 (en) | 1986-01-31 |
| FI853275A0 (fi) | 1985-08-27 |
| HU195421B (en) | 1988-05-30 |
| FI87992C (fi) | 1993-03-25 |
| EP0173293A3 (en) | 1987-07-01 |
| FI87992B (fi) | 1992-12-15 |
| KR870001830A (ko) | 1987-03-28 |
| EP0173293A2 (en) | 1986-03-05 |
| ZA856482B (en) | 1986-05-28 |
| AU579177B2 (en) | 1988-11-17 |
| ES546545A0 (es) | 1986-07-16 |
| IE852134L (en) | 1986-02-28 |
| KR920007832B1 (ko) | 1992-09-18 |
| AR242341A1 (es) | 1993-03-31 |
| ATE68972T1 (de) | 1991-11-15 |
| ES8608866A1 (es) | 1986-07-16 |
| AU4669285A (en) | 1986-03-06 |
| DK164642B (da) | 1992-07-27 |
| JPS6160613A (ja) | 1986-03-28 |
| DK384985A (da) | 1986-03-01 |
| DK164642C (da) | 1992-12-14 |
| PH21083A (en) | 1987-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT81028B (pt) | Processo para a preparacao de composicoes farmaceuticas anti-histaminicas de fusao a quente em condicoes de proporcionarem uma libertacao prolongada do produto anti-histaminico, designadamente o alfa-(p-tert-butilfenil)-4-(alfa-hidroxi-alfa-fenilbenzil)-1-piperidinobutanol (terfenadina) | |
| US3146167A (en) | Method of preparing sustained release pellets and products thereof | |
| JP5296314B2 (ja) | 制御放出製剤 | |
| ES2251985T3 (es) | Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion. | |
| US8663692B1 (en) | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same | |
| JP3768536B2 (ja) | 低温溶融性薬物と制御放出のための添加物との均質混合物 | |
| PT1809261E (pt) | Sistema de cápsula mole não gelatinosa | |
| JPS60139617A (ja) | 可咀しやく性の被覆一体形軟弾性ゼラチンカプセルおよびその製造法 | |
| HUT75670A (en) | Soft-shelled gelatin encapsulated particles and process for its production | |
| BRPI0720118B1 (pt) | forma sólida de dosagem farmacêutica para administração oral compreendendo cloridrato de valganciclovir | |
| EP2205223A1 (de) | Hot melt-befüllte weichkapseln | |
| AU2003285189A1 (en) | Oral testosterone delivery system with improved sustained release | |
| JPH03200728A (ja) | 医薬組成物 | |
| CN101500545A (zh) | 含布洛芬的液体填充硬胶囊 | |
| RU2177315C2 (ru) | Фармацевтические микросферические частицы вальпроиновой кислоты для перорального введения | |
| HU229103B1 (en) | Self emulsifying drug delivery system | |
| ES2233971T3 (es) | Procedimiento de produccion de una preparacion granular. | |
| CN102172345A (zh) | 用于调配包含至少一种基于分子量选择的鱼明胶的快速分散剂型的方法 | |
| RU2328271C2 (ru) | Дерматологический карандаш с загущенной мазью | |
| SK3396A3 (en) | Pharmaceutically acceptable composition and preparation method thereof | |
| US20080305177A1 (en) | Method of administering testosterone | |
| PT911038E (pt) | Composicao anidra a base de lactulose | |
| US9314441B2 (en) | Two phase pharmaceutical delivery system | |
| CN1044319C (zh) | 热熔融抗组胺组合物的制备方法 | |
| JPS6226213A (ja) | 温水徐溶性ゲル組成物 |